Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,176 | 15 | 99.7% |
| Food and Beverage | $28.03 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11,176 | 15 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $28.03 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $620.00 | 1 | Merck Sharp & Dohme LLC ($620.00) |
| 2023 | $1,878 | 3 | Merck Sharp & Dohme LLC ($1,878) |
| 2022 | $603.50 | 1 | Merck Sharp & Dohme LLC ($603.50) |
| 2021 | $2,366 | 5 | Merck Sharp & Dohme LLC ($2,338) |
| 2020 | $2,231 | 3 | Merck Sharp & Dohme Corporation ($2,231) |
| 2019 | $3,506 | 4 | Merck Sharp & Dohme Corporation ($3,506) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $620.00 | General |
| Category: VACCINE | ||||||
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $348.75 | General |
| Category: VACCINE | ||||||
| 06/14/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $891.25 | General |
| Category: VACCINE | ||||||
| 01/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $637.50 | General |
| Category: VACCINE | ||||||
| 06/29/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $603.50 | General |
| Category: VACCINE | ||||||
| 12/08/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,062.50 | General |
| Category: VACCINE | ||||||
| 06/30/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $531.25 | General |
| Category: VACCINE | ||||||
| 06/30/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ANTIBIOTIC | ||||||
| 04/09/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: ANTIBIOTIC | ||||||
| 01/20/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $743.75 | General |
| Category: VACCINE | ||||||
| 12/04/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| Category: VACCINE | ||||||
| 06/10/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $956.25 | General |
| Category: VACCINE | ||||||
| 01/15/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: VACCINE | ||||||
| 11/06/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $956.25 | General |
| Category: VACCINE | ||||||
| 06/26/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $637.50 | General |
| Category: VACCINE | ||||||
| 03/29/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $1,062.50 | General |
| Category: VACCINE | ||||||
| 03/29/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 67 | 110 | $42,620 | $8,635 |
| 2022 | 2 | 52 | 82 | $30,418 | $6,334 |
| 2021 | 3 | 112 | 164 | $13,100 | $9,396 |
| 2020 | 3 | 70 | 118 | $10,421 | $7,487 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 85 | $23,545 | $5,249 | 22.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $19,075 | $3,386 | 17.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 64 | $17,152 | $3,559 | 20.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $13,266 | $2,775 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 44 | 82 | $6,491 | $4,256 | 65.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $4,283 | $3,478 | 81.2% |
| 99451 | Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | Facility | 2021 | 46 | 60 | $2,327 | $1,662 | 71.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 70 | $5,205 | $4,005 | 76.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 18 | $4,097 | $2,592 | 63.3% |
| 99451 | Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | Facility | 2020 | 21 | 30 | $1,119 | $890.70 | 79.6% |
About Dr. Priya Sampathkumar, M.D
Dr. Priya Sampathkumar, M.D is a Infectious Disease healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891769139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Priya Sampathkumar, M.D has received a total of $11,204 in payments from pharmaceutical and medical device companies, with $620.00 received in 2024. These payments were reported across 17 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($11,176).
As a Medicare-enrolled provider, Sampathkumar has provided services to 301 Medicare beneficiaries, totaling 474 services with total Medicare billing of $31,852. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Rochester, MN
- Active Since 02/14/2006
- Last Updated 08/20/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1891769139
Products in Payments
- V114 (Biological) $5,738
- NUZYRA (Drug) $28.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Rochester
Robin Patel, M.d, M.D
Infectious Disease — Payments: $270,548
Ann Falsey, Md, MD
Infectious Disease — Payments: $191,692
Edward Walsh, Md, MD
Infectious Disease — Payments: $131,419
Emil Lesho, D.o, D.O
Infectious Disease — Payments: $65,937
Zelalem Temesgen, M.d, M.D
Infectious Disease — Payments: $56,223
Dr. Angela Branche, Md, MD
Infectious Disease — Payments: $50,957